These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 37410912)

  • 1. Transactive response DNA-binding protein 43 is enriched at the centrosome in human cells.
    Bodin A; Greibill L; Gouju J; Letournel F; Pozzi S; Julien JP; Renaud L; Bohl D; Millecamps S; Verny C; Cassereau J; Lenaers G; Chevrollier A; Tassin AM; Codron P
    Brain; 2023 Sep; 146(9):3624-3633. PubMed ID: 37410912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyotrophic lateral sclerosis and frontotemporal lobar degeneration: a spectrum of TDP-43 proteinopathies.
    Geser F; Lee VM; Trojanowski JQ
    Neuropathology; 2010 Apr; 30(2):103-12. PubMed ID: 20102519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TDP-43 aggregation in neurodegeneration: are stress granules the key?
    Dewey CM; Cenik B; Sephton CF; Johnson BA; Herz J; Yu G
    Brain Res; 2012 Jun; 1462():16-25. PubMed ID: 22405725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [FTLD/ALS as TDP-43 proteinopathies].
    Ishihara T; Ariizumi Y; Shiga A; Yokoseki A; Sato T; Toyoshima Y; Kakita A; Takahashi H; Nishizawa M; Onodera O
    Rinsho Shinkeigaku; 2010 Nov; 50(11):1022-4. PubMed ID: 21921552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mislocalization of Nup62 Contributes to TDP-43 Proteinopathy in ALS/FTLD.
    Nag N; Tripathi T
    ACS Chem Neurosci; 2022 Sep; 13(17):2544-2546. PubMed ID: 36001801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease animal models of TDP-43 proteinopathy and their pre-clinical applications.
    Liu YC; Chiang PM; Tsai KJ
    Int J Mol Sci; 2013 Oct; 14(10):20079-111. PubMed ID: 24113586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Mechanisms Underlying TDP-43 Pathology in Cellular and Animal Models of ALS and FTLD.
    Wood A; Gurfinkel Y; Polain N; Lamont W; Lyn Rea S
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The RNA-binding motif 45 (RBM45) protein accumulates in inclusion bodies in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP) patients.
    Collins M; Riascos D; Kovalik T; An J; Krupa K; Krupa K; Hood BL; Conrads TP; Renton AE; Traynor BJ; Bowser R
    Acta Neuropathol; 2012 Nov; 124(5):717-32. PubMed ID: 22993125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physiological functions and pathobiology of TDP-43 and FUS/TLS proteins.
    Ratti A; Buratti E
    J Neurochem; 2016 Aug; 138 Suppl 1():95-111. PubMed ID: 27015757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible concurrence of TDP-43, tau and other proteins in amyotrophic lateral sclerosis/frontotemporal lobar degeneration.
    Takeda T
    Neuropathology; 2018 Feb; 38(1):72-81. PubMed ID: 28960544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct TDP-43 inclusion morphologies in frontotemporal lobar degeneration with and without amyotrophic lateral sclerosis.
    Tan RH; Yang Y; Kim WS; Dobson-Stone C; Kwok JB; Kiernan MC; Halliday GM
    Acta Neuropathol Commun; 2017 Oct; 5(1):76. PubMed ID: 29078806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TDP-43 transports ribosomal protein mRNA to regulate axonal local translation in neuronal axons.
    Nagano S; Jinno J; Abdelhamid RF; Jin Y; Shibata M; Watanabe S; Hirokawa S; Nishizawa M; Sakimura K; Onodera O; Okada H; Okada T; Saito Y; Takahashi-Fujigasaki J; Murayama S; Wakatsuki S; Mochizuki H; Araki T
    Acta Neuropathol; 2020 Nov; 140(5):695-713. PubMed ID: 32803350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TDP-43: a DNA and RNA binding protein with roles in neurodegenerative diseases.
    Warraich ST; Yang S; Nicholson GA; Blair IP
    Int J Biochem Cell Biol; 2010 Oct; 42(10):1606-9. PubMed ID: 20601083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of transactive response DNA-binding protein-43 in amyotrophic lateral sclerosis and frontotemporal dementia.
    Mackenzie IR; Rademakers R
    Curr Opin Neurol; 2008 Dec; 21(6):693-700. PubMed ID: 18989115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reappraisal of the anatomical spreading and propagation hypothesis about TDP-43 aggregation in amyotrophic lateral sclerosis and frontotemporal lobar degeneration.
    Riku Y
    Neuropathology; 2020 Oct; 40(5):426-435. PubMed ID: 32157757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular dissection of TDP-43 proteinopathies.
    Hasegawa M; Nonaka T; Tsuji H; Tamaoka A; Yamashita M; Kametani F; Yoshida M; Arai T; Akiyama H
    J Mol Neurosci; 2011 Nov; 45(3):480-5. PubMed ID: 21678031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers for diseases with TDP-43 pathology.
    Steinacker P; Barschke P; Otto M
    Mol Cell Neurosci; 2019 Jun; 97():43-59. PubMed ID: 30399416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TDP-43 induces mitochondrial damage and activates the mitochondrial unfolded protein response.
    Wang P; Deng J; Dong J; Liu J; Bigio EH; Mesulam M; Wang T; Sun L; Wang L; Lee AY; McGee WA; Chen X; Fushimi K; Zhu L; Wu JY
    PLoS Genet; 2019 May; 15(5):e1007947. PubMed ID: 31100073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathological hallmarks of amyotrophic lateral sclerosis/frontotemporal lobar degeneration in transgenic mice produced with TDP-43 genomic fragments.
    Swarup V; Phaneuf D; Bareil C; Robertson J; Rouleau GA; Kriz J; Julien JP
    Brain; 2011 Sep; 134(Pt 9):2610-26. PubMed ID: 21752789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TDP-43 is consistently co-localized with ubiquitinated inclusions in sporadic and Guam amyotrophic lateral sclerosis but not in familial amyotrophic lateral sclerosis with and without SOD1 mutations.
    Maekawa S; Leigh PN; King A; Jones E; Steele JC; Bodi I; Shaw CE; Hortobagyi T; Al-Sarraj S
    Neuropathology; 2009 Dec; 29(6):672-83. PubMed ID: 19496940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.